High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III

Background/Aim: Several risk factors for recurrence have been identified in stage II colorectal cancer. However, in contrast to stage III, the benefits of adjuvant chemotherapy for these patients remain controversial. We hypothesized that the different impacts of chemotherapy may be due to different...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :In Vivo
Главные авторы: NOZAWA, HIROAKI, KAWAI, KAZUSHIGE, HATA, KEISUKE, TANAKA, TOSHIAKI, NISHIKAWA, TAKESHI, OTANI, KENSUKE, SASAKI, KAZUHITO, KANEKO, MANABU, EMOTO, SHIGENOBU, MURONO, KOJI
Формат: Artigo
Язык:Inglês
Опубликовано: International Institute of Anticancer Research 2018
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6199616/
https://ncbi.nlm.nih.gov/pubmed/30150450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11370
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы